RT @DrMiniDey: Safety update for #filgotinib in #RA over ~2.2yrs treatment ðð¼Well-tolerated with no ne safety conc
Tweet Content
Safety update for #filgotinib in #RA over ~2.2yrs treatment
👉🏼Well-tolerated with no ne safety concerns since 2020
👉🏼AE incidence rates decreased or remained stable
👉🏼Slight incr rates of NMSC & non-NMSC malignancies
Abs#1698 #ACR21 @RheumNow
https://t.co/0jbZFVgiyN https://t.co/yOlntLwQlU
Links
Integrated Safety Analysis Update for Filgotinib in Patients with Moderately to…
https://acrabstracts.org/abstract/integrated-safety-analysis-update-for-filgoti…
Show on Archive Page
On
Display in Search Results
On
PDQ
Off